CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 54 enrolled
Drug / intervention
Sleep Restrictionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02835261
NCT02835261N/ACompleted

Impact of Sleep Restriction on Cardiometabolic Risk Factors in Pre vs Postmenopausal Women

Columbia University·interventional·Posted Jul 18, 2016·Updated Oct 14, 2025

In Brief

A clinical study evaluating Sleep Restriction for Sleep and 2 related conditions. Completed, enrolled 54 participants across 1 site.

Detailed Summary

The overall goal of this project is to test the hypothesis that long-term, sustained sleep restriction (SR), in women, will lead to increased cardio-metabolic risk. This will be characterized by increases in visceral adiposity, unhealthy lifestyle behaviors (poor dietary quality and low physical activity) and cardio-metabolic risk factors (blood pressure, glucose intolerance) relative to habitual sleep (HS). The investigators expect these changes to be worse in pre- compared to post-menopausal women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 18, 2016
Enrollment StartSep 1, 2016
Primary CompletionFeb 25, 2021
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 10.0 years ago

Interventions

Sleep Restrictionother

Mild sleep restriction (-1.5 h/night) over a period of 6 weeks